Keisuke Aiba

1.6k total citations
71 papers, 992 citations indexed

About

Keisuke Aiba is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Keisuke Aiba has authored 71 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 17 papers in Surgery. Recurrent topics in Keisuke Aiba's work include Cancer Treatment and Pharmacology (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Nausea and vomiting management (8 papers). Keisuke Aiba is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Nausea and vomiting management (8 papers). Keisuke Aiba collaborates with scholars based in Japan, United States and France. Keisuke Aiba's co-authors include C J Allegra, Edward Chu, Sitki Copur, J C Drake, Toshiki Matsubara, Mototsugu Shimokawa, Yasuhiro Arakawa, Kazuo Tamura, Toshiaki Saeki and Shingo Yano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Keisuke Aiba

66 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Aiba Japan 15 500 333 284 194 149 71 992
Anuhya Kommalapati United States 18 603 1.2× 373 1.1× 254 0.9× 305 1.6× 133 0.9× 63 1.1k
Petr Szturz Czechia 18 494 1.0× 307 0.9× 350 1.2× 269 1.4× 85 0.6× 85 1.2k
J. Feng China 15 660 1.3× 221 0.7× 425 1.5× 291 1.5× 175 1.2× 71 1.0k
Preston D. Steen United States 18 579 1.2× 120 0.4× 329 1.2× 259 1.3× 125 0.8× 47 1.0k
Aytuğ Üner Türkiye 15 400 0.8× 182 0.5× 189 0.7× 131 0.7× 56 0.4× 70 786
Gertrude Peterson United States 23 671 1.3× 571 1.7× 214 0.8× 151 0.8× 233 1.6× 50 1.9k
Suzanne Berlin United States 15 408 0.8× 119 0.4× 204 0.7× 333 1.7× 223 1.5× 37 1.3k
Alexis D. Leal United States 15 545 1.1× 163 0.5× 128 0.5× 244 1.3× 188 1.3× 57 888
Seung‐Hoon Beom South Korea 17 459 0.9× 230 0.7× 361 1.3× 150 0.8× 150 1.0× 69 901
Eva Honsová Czechia 19 177 0.4× 235 0.7× 283 1.0× 230 1.2× 154 1.0× 73 1.3k

Countries citing papers authored by Keisuke Aiba

Since Specialization
Citations

This map shows the geographic impact of Keisuke Aiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Aiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Aiba more than expected).

Fields of papers citing papers by Keisuke Aiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Aiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Aiba. The network helps show where Keisuke Aiba may publish in the future.

Co-authorship network of co-authors of Keisuke Aiba

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Aiba. A scholar is included among the top collaborators of Keisuke Aiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Aiba. Keisuke Aiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Isao, Kazuo Tamura, Toshihiro Miyamoto, et al.. (2019). Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan. In Vivo. 33(4). 1355–1362. 4 indexed citations
2.
Ito, Yuta, et al.. (2017). [Diffuse large B-cell lymphoma complicated with drug-induced vasculitis during administration of pegfilgrastim].. PubMed. 58(11). 2238–2242. 10 indexed citations
3.
4.
Arakawa, Yasuhiro, Miho Tamura, Keisuke Aiba, et al.. (2017). Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report. Oncology Letters. 14(3). 3039–3042. 24 indexed citations
5.
Inui, Yumiko, Hiroshi Matsuoka, Kimikazu Yakushijin, et al.. (2015). Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leukemia & lymphoma. 56(11). 3045–3051. 71 indexed citations
6.
Sano, Koji, et al.. (2015). Reversible posterior leukoencephalopathy syndrome during R-ICE therapy for malignant lymphoma. Annals of Oncology. 26. vii110–vii110.
7.
Arakawa, Yasuhiro, Miho Tamura, Keisuke Aiba, et al.. (2015). Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapy. Journal of Infection and Chemotherapy. 21(7). 502–506. 7 indexed citations
8.
Tamura, Kazuo, Keisuke Aiba, Toshiaki Saeki, et al.. (2015). Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. International Journal of Clinical Oncology. 20(5). 855–865. 98 indexed citations
9.
Suzuki, Kazuhito, Yasuhito Terui, Noriko Nishimura, et al.. (2014). Rapid Progression of Anemia Related to Tumor-lysis Syndrome Associated with Bortezomib Treatment in Myeloma Patients. Japanese Journal of Clinical Oncology. 44(5). 435–441. 6 indexed citations
10.
Nagasaki, Eijiro, Masami Yuda, Yasuhiro Arakawa, et al.. (2012). Complete response of esophageal small cell carcinoma amrubicin treatment. Journal of Infection and Chemotherapy. 19(4). 770–775. 4 indexed citations
11.
Arakawa, Yasuhiro & Keisuke Aiba. (2012). [Predictive biomarkers for response to irinotecan, platinum drugs, and taxanes].. PubMed. 39(11). 1608–12. 1 indexed citations
12.
Arakawa, Yasuhiro, Shinobu Saito, Hisashi Yamada, & Keisuke Aiba. (2009). Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-XL and promotes apoptosis of MCF-7 breast cancer cells. APOPTOSIS. 14(9). 1076–1085. 16 indexed citations
13.
Takahashi, Shunji, Keisuke Aiba, Yoshinori Ito, et al.. (2007). Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients. Cancer Science. 98(10). 1609–1616. 12 indexed citations
14.
Okawa, Yutaka, Keisuke Aiba, Akio Hirano, et al.. (2004). Successful combination therapy with trastuzumab and paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer. Breast Cancer. 11(3). 309–312. 4 indexed citations
15.
Saeki, Toshiaki, Kenji Eguchi, Takahiko Sugiura, et al.. (2004). Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumors. Cancer Chemotherapy and Pharmacology. 54(5). 459–468. 2 indexed citations
16.
Tada, Keiichiro, Yoshinori Ito, Kiyohiko Hatake, et al.. (2003). Severe infusion reaction induced by trastuzumab: A case report. Breast Cancer. 10(2). 167–169. 9 indexed citations
17.
Fujiwara, Keiichi, Takashi Saotome, Nobuyuki Mizunuma, et al.. (2002). Irinotecan hydrochloride for the treatment of recurrent and refractory non‐Hodgkin lymphoma. Cancer. 94(3). 594–600. 12 indexed citations
18.
Aiba, Keisuke, et al.. (2000). Chemoradiotherapy of Locally Advanced Esophageal Cancer.. 115(5). 535–547. 68 indexed citations
19.
Ito, Yoshinori, Taketo Mukaiyama, Makoto Ogawa, et al.. (1999). Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up. Cancer Chemotherapy and Pharmacology. 43(1). 8–12. 2 indexed citations
20.
Copur, Sitki, Keisuke Aiba, J C Drake, C J Allegra, & Edward Chu. (1995). Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochemical Pharmacology. 49(10). 1419–1426. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026